| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.88B | 3.00B | 2.44B | 2.78B | 3.31B |
| Gross Profit | 3.80B | 2.98B | 2.43B | 2.76B | 3.29B |
| EBITDA | 856.62M | 532.76M | 368.18M | 732.69M | 1.15B |
| Net Income | 591.92M | 378.28M | 255.48M | 476.52M | 740.12M |
Balance Sheet | |||||
| Total Assets | 5.36B | 4.17B | 3.70B | 3.62B | 3.80B |
| Cash, Cash Equivalents and Short-Term Investments | 3.01B | 939.71M | 651.73M | 786.29M | 719.53M |
| Total Debt | 1.16B | 923.32M | 844.39M | 687.82M | 721.04M |
| Total Liabilities | 3.04B | 2.23B | 1.92B | 1.89B | 2.17B |
| Stockholders Equity | 2.03B | 1.71B | 1.58B | 1.54B | 1.32B |
Cash Flow | |||||
| Free Cash Flow | 1.18B | 958.05M | 437.91M | 508.19M | 1.36B |
| Operating Cash Flow | 1.26B | 988.15M | 457.95M | 531.38M | 1.38B |
| Investing Cash Flow | -98.33M | -67.43M | 15.62M | 313.30M | -705.89M |
| Financing Cash Flow | -635.62M | -628.55M | -557.23M | -735.57M | -925.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $5.15B | 21.73 | ― | 3.69% | 51.19% | 456.59% | |
70 Outperform | $12.80B | 23.56 | 31.66% | 0.95% | 27.00% | 63.47% | |
69 Neutral | $12.27B | 20.53 | 11.72% | 1.43% | 7.54% | 2.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $11.58B | 25.51 | 20.47% | 1.33% | 20.99% | 25.02% | |
62 Neutral | $5.82B | 20.78 | 21.65% | 1.63% | 12.77% | 36.43% | |
59 Neutral | $11.13B | 19.02 | 6.13% | 2.52% | -5.41% | 25.28% |
On February 3, 2026, Evercore Inc.’s board of directors appointed veteran antitrust lawyer Christine Varney as a director, effective March 1, 2026, for a term running until the company’s 2026 annual meeting of stockholders, and concurrently expanded the board from ten to eleven members. Varney, the former chair of Cravath’s antitrust practice and a former Assistant Attorney General heading the U.S. Department of Justice Antitrust Division as well as a past Federal Trade Commission commissioner, will join Evercore’s Audit Committee and its Nominating and Corporate Governance Committee and receive standard non-management director compensation plus a $50,000 restricted stock unit grant, signaling Evercore’s intent to deepen its governance and regulatory expertise at a time when antitrust scrutiny remains a key factor in complex advisory mandates.
The most recent analyst rating on (EVR) stock is a Hold with a $369.00 price target. To see the full list of analyst forecasts on Evercore Partners stock, see the EVR Stock Forecast page.